Adverse Event Clinical Research R4 Backport, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-backport-ig/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
Generated Narrative: MedicationStatement
Resource MedicationStatement "example003"
status: active
medication: Little Pink Pill for water retention ()
subject: Patient/JanetPatient: Janet " CLINICAL TRIAL PATIENT"
effective: 2023-02-01
dateAsserted: 2023-04-12
informationSource: Patient/JanetPatient: Janet " CLINICAL TRIAL PATIENT"
reasonReference: Observation/blood-pressure-janet
note: Patient cannot remember the name of the tablet, but takes it every day in the morning for water retention
dosage
sequence: 1
text: 1 tablet per day
asNeeded: false
route: Oral Route (SNOMED CT#26643006)
doseAndRate
maxDosePerPeriod: 1/1 d (Details: UCUM code d = 'd')